JMP Securities Initiates Coverage On Ironwood Pharmaceuticals with Market Outperform Rating, Announces Price Target of $22
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst Jason Butler has initiated coverage on Ironwood Pharmaceuticals with a Market Outperform rating and a price target of $22.
September 28, 2023 | 9:55 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Ironwood Pharmaceuticals has been given a Market Outperform rating by JMP Securities with a price target of $22.
The initiation of coverage by JMP Securities with a Market Outperform rating and a price target of $22 indicates a positive outlook for Ironwood Pharmaceuticals. This could potentially attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100